32 participants
A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2014-09-22
- Start Date:
- 2012-12-31
- Completion:
- 2013-04-30
Conditions
- Healthy
- Renal Impairment
Interventions
- DRUG
No Results Yet